The patent badge is an abbreviated version of the USPTO patent document. The patent badge does contain a link to the full patent document.

The patent badge is an abbreviated version of the USPTO patent document. The patent badge covers the following: Patent number, Date patent was issued, Date patent was filed, Title of the patent, Applicant, Inventor, Assignee, Attorney firm, Primary examiner, Assistant examiner, CPCs, and Abstract. The patent badge does contain a link to the full patent document (in Adobe Acrobat format, aka pdf). To download or print any patent click here.

Date of Patent:
Jun. 23, 2015

Filed:

Nov. 02, 2010
Applicants:

Seung Ki Lee, Seoul, KR;

Byeong Moon Kim, Seoul, KR;

Seung Ju Cho, Gyeonggi-do, KR;

Young Jong Kim, Seoul, KR;

Inventors:

Seung Ki Lee, Seoul, KR;

Byeong Moon Kim, Seoul, KR;

Seung Ju Cho, Gyeonggi-do, KR;

Young Jong Kim, Seoul, KR;

Assignee:

SNU R&DB Foundation, Seoul, KR;

Attorney:
Primary Examiner:
Int. Cl.
CPC ...
A01N 43/04 (2006.01); C07H 19/16 (2006.01); A61K 31/70 (2006.01); C07H 19/14 (2006.01); A61K 31/7068 (2006.01); C07H 1/00 (2006.01); A61K 31/519 (2006.01);
U.S. Cl.
CPC ...
C07H 19/14 (2013.01); A61K 31/7068 (2013.01); C07H 1/00 (2013.01); A61K 31/519 (2013.01);
Abstract

The present invention relates to a CDK-inhibiting pyrrolopyrimidine carboxamide derivative or a pharmaceutically acceptable salt thereof, and a pharmaceutical composition comprising the same as an active ingredient for preventing or treating liver cell cancer. Compositions comprising a pyrrolopyrimidine carboxamide derivative of the present invention suppress the cell growth of SNU-354 cell, which is a liver cancer stem cell in humans, by inhibiting CDK1 and CDK2, and induces cell apoptosis of the cell by inhibiting CDK7 and CDK 7. Such compositions are useful for preventing or treating liver cell cancer.


Find Patent Forward Citations

Loading…